Skip to main content

Tracon Pharmaceuticals, Inc.

TCONDelisted Jul 19, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001394319

Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.

13F holders, Q1 2024

Institutional positions in Tracon Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
29
+5 vs. Q4 2023
Shares held
3.25M
−1.92M (−37.2%) vs. Q4 2023
Total value
$1.39M
+$487.3K (+53.9%) vs. Q4 2023
New holders
11
3 more added
Sold out
6
5 more reduced

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TCON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 29 institutions
Q1 2021: 42 institutionsQ2 2021: 44 institutionsQ3 2021: 45 institutionsQ4 2021: 35 institutionsQ1 2022: 35 institutionsQ2 2022: 31 institutionsQ3 2022: 33 institutionsQ4 2022: 32 institutionsQ1 2023: 32 institutionsQ2 2023: 27 institutionsQ3 2023: 21 institutionsQ4 2023: 24 institutionsQ1 2024: 29 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2024: $1.39M
Q1 2021: $72.8MQ2 2021: $58.5MQ3 2021: $39.6MQ4 2021: $25.4MQ1 2022: $24.0MQ2 2022: $19.7MQ3 2022: $16.5MQ4 2022: $14.6MQ1 2023: $18.8MQ2 2023: $2.90MQ3 2023: $1.66MQ4 2023: $903.4KQ1 2024: $1.39MQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding TCON and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 202429$1.39M
Q4 202324$903.4K
Q3 202321$1.66M
Q2 202327$2.90M
Q1 202332$18.8M
Q4 202232$14.6M
Q3 202233$16.5M
Q2 202231$19.7M
Q1 202235$24.0M
Q4 202135$25.4M
Q3 202145$39.6M
Q2 202144$58.5M
Q1 202142$72.8M

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Tracon Pharmaceuticals, Inc.; share changes are against Q4 2023.

Institutions holding TCON in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
LPL Financial LLC450,650$193.7K0.00%+450,650New
Acadian Asset Management LLC413,909$176.0K0.00%00.0%Unchanged
Squarepoint Ops LLC388,985$167.2K0.00%−23,286−5.6%Reduced
Renaissance Technologies LLC300,238$129.0K0.00%+202,200+206.2%Added
Geode Capital Management, LLC286,709$123.2K0.00%+77,923+37.3%Added
Vanguard Group Inc262,772$112.9K0.00%00.0%Unchanged
BlackRock Inc.260,084$111.8K0.00%−1,178−0.5%Reduced
Jane Street Group, LLC182,307$78.4K0.00%+182,307New
UBS Group AG91,333$39.3K0.00%+91,333New
Johnson & Johnson84,003$36.1K0.00%00.0%Unchanged
Susquehanna International Group, LLP77,868$33.5K0.00%+77,868New
State Street Corp75,154$32.3K0.00%00.0%Unchanged
Millennium Management LLC74,658$32.1K0.00%−116,795−61.0%Reduced
CI Private Wealth, LLC57,455$24.7K0.00%00.0%Unchanged
HRT Financial LP54,364$23.0K0.00%+54,364New
Two Sigma Investments, LP34,822$15.0K0.00%+34,822New
XTX Topco Ltd27,965$12.0K0.00%+27,965New
ETF Portfolio Partners, Inc.24,641$10.6K0.00%+24,641New
Northern Trust Corp21,691$9.32K0.00%00.0%Unchanged
SpiderRock Advisors, LLC22,983$8.30K0.00%+22,983New
Hoylecohen, LLC13,000$5.59K0.00%00.0%Unchanged
Jump Financial, LLC10,500$4.51K0.00%+10,500New
Bank of New York Mellon Corp10,259$4.41K0.00%00.0%Unchanged
Mercer Global Advisors Inc10,000$4.00K0.00%+10,000New
Tower Research Capital LLC (TRC)7,579$3.26K0.00%−2,786−26.9%Reduced
Game Plan Financial Advisors, LLC1,000$4300.00%00.0%Unchanged
Truvestments Capital LLC318$1370.00%00.0%Unchanged
Wells Fargo & Company207$890.00%+3+1.5%Added
Royal Bank of Canada150$00.00%−101−40.2%Reduced
Ikarian Capital, LLC0$00.00%−2,765,530−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−258,844−100.0%Sold out
GTS Securities LLC0$00.00%−15,794−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−800−100.0%Sold out
Morgan Stanley0$00.00%−200−100.0%Sold out
Cutler Group LP0$00.00%−1,200−100.0%Sold out